DurAVR™ THV EU-EFS
NCT: NCT06510855 · ACTIVE_NOT_RECRUITING
NCT IDNCT06510855
StatusACTIVE_NOT_RECRUITING
Start Date2025-01-21
Completion2031-08
Brief Summary
A prospective, non-randomized, single-arm, multi-center study designed to evaluate the safety and feasibility of DurAVR™ THV System in the treatment of subjects with symptomatic severe native aortic stenosis or failed surgical aortic bioprosthetic valves.
Frequently Asked Questions
What is DurAVR™ THV EU-EFS?
DurAVR™ THV EU-EFS is a clinical trial registered under NCT06510855. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06510855?
The current status of NCT06510855 (DurAVR™ THV EU-EFS) is: ACTIVE_NOT_RECRUITING.
When did DurAVR™ THV EU-EFS start?
DurAVR™ THV EU-EFS started on 2025-01-21.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.